Intravenous (IV) Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By End-use, By Region, And Segment Forecasts, 2023 - 2030

IV Hydration Therapy Market Size & Trends

The global intravenous (IV) hydration therapy market size was valued at USD 2.32 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.97% from 2023 to 2030. The growth of the market is attributed to therising prevalence of chronic diseases, the growing popularity of wellness and beauty treatments, and the increasing availability of IV hydration therapy clinics, as well as the ease of use associated with this therapy. The procedure has gained immense popularity in recent times, owing to the advantages associated with it, and the use of the therapy in a wide array of applications.

A team of academics led by scientists from the Washington University School of Medicine announced new discoveries in August 2020. According to their findings, people became ill when infected with COVID-19 because their immune systems do not provide the essential amount of protection to prevent significant symptoms. As per these specialists, boosting the immune system could be an effective COVID-19 treatment. This is when IV hydration therapy came into the limelight as a method to boost an individual’s immune system, thus driving its demand during the pandemic.

Furthermore, IV hydration therapy has gained immense popularity in the cosmetic industry, owing to the skincare benefits offered by the procedure. It has been found through extensive research that the therapy helps in providing beauty treatment by hydrating the skin, further enhancing the appearance of an individual. IV hydration therapy is believed to enhance the normal production of elastin and collagen, which are responsible for maintaining youthful and healthy-looking skin. This can help to reduce the appearance of wrinkles and fine lines over time.

Moreover, technological advancements in the healthcare industry aided by the benefits of IV hydration therapy, including better convenience, cost-effectiveness, better outcomes, and higher safety standards, are further fueling the growth of the market. The growing geriatric population that is affected by chronic conditions requiring infusion therapies is increasing their demand and use. Moreover, efforts are being taken by key players while taking into consideration consumer demands, to provide effective and enhanced results and help in the better adoption of the technology globally.

However, IV hydration therapy, despite displaying several benefits for the physical and overall wellness of an individual, faces a major setback to its growth, which is that none of the therapies are approved by the FDA, signifying that the benefits associated with them are not clinically validated.

Service Insights

Based on service, the energy boosters segment held the largest market share of 26.34% in 2022. The dominance of the segment is attributed to the increasing popularity of these therapies in providing rapid and effective energy requirements. Energy IV therapy contains antioxidants, amino acids, and nutrients that aid in increasing energy levels, as well as improving mental clarity, mood, and focus. They tend to provide a boost in energy naturally and safely without incorporating stimulants or drugs, which is expected to drive the demand.

However, the skin care segment is expected to expand at the fastest growth rate over the forecast period. The growth can be attributed to the increasing patient spending on cosmetic procedures and beautification. Beauty IV drips are made up of a special combination of minerals, electrolytes, and vitamins that help them to target and remove free radicals that lead to aging. Additionally, they cleanse the body naturally and remove toxins to give a youthful appearance to the skin. All these beauty benefits offered by the products have resulted in the growing demand for skin care services.

Component Insights

Based on the component, the medicated segment held the largest revenue share of 67.54% in the IV hydration therapy market in 2022. This dominance is attributed to the growing demand for medications to be provided to patients through the IV route, along with key players focusing on developing customizable medicated IV hydration therapy solutions.

For instance, Drip Hydration offers Stomach Flu IV treatment, which comprises an infusion of a blend of electrolytes, vitamins, fluids, and drugs to heal stomach flu symptoms and restore hydration of the body within 30-60 minutes. This IV medication contains Vitamin B12, B-Complex vitamins, Vitamin C, Zofran, and Pepcid. Zofran is an anti-nausea/vomiting medication that helps to reduce nausea and vomiting caused by stomach flu.

On the other hand, the non-medicated segment is expected to grow at the fastest rate over the forecast period. The segment advancement can be attributed to the rising demand for therapies in beauty- and energy-boosting applications. The constantly growing global population is widely adopting IV hydration therapy for hydrating their skin to retain its natural glow.

End-use Insights

Based on end-use, hospitals & clinics held the dominant market share of 42.01% in 2022. The segment growth can be attributed to the rising need for hospitalization due to an increase in the number of people suffering from chronic disorders. On average, hospitalizations may last for 4-5 days, driving the need for supplying medications and nutrients to patients through IV routes. Moreover, these services are offered in hospitals at a lower cost under the supervision of a licensed physician, making it a prime location for IV hydration therapy, thus driving market growth.

However, the home healthcare segment is expected to witness the fastest growth over the forecast period. The growth of the segment is due to the rapidly increasing geriatric population that is prone to various disorders. Moreover, the emergence of the COVID-19 pandemic, which highlighted the necessity for medical equipment, particularly in a home-based scenario where the virus is transmitted through physical contact, resulted in the higher adoption of homecare services.

Regional Insights

North America dominated the market for IV hydration therapy with a share of 46.82% in 2022 and is anticipated to maintain its dominance over the forecast period. The high share of the regional market is due to the unprecedented adoption of IV hydration therapy in the U.S. There is an increasing demand for energy and immune boosters in the region, owing to rising incidences of chronic diseases.

The region boasts a high disposable income and high patient spending on overall wellness, which increases the adoption of the market. Moreover, key players in the region are constantly focusing on introducing newer technologies into the market to meet the changing consumer demands, which is further anticipated to drive regional market growth. For instance, in December 2022, The DRIPBaR entered a partnership with entrepreneur and investor Kevin Harrington, who will be a major investor in the IV therapy franchise. The franchise has been gaining immense acceptance across the region.

On the other hand, Asia Pacific is estimated to be the fastest-growing region over the forecast period. The region's expansion can be attributable to the increased awareness of IV hydration therapy and its associated benefits. Moreover, the market is expected to witness a surge in demand owing to initiatives being taken by healthcare facilities in the region, as a result of the rising occurrence of various immunity disorders. For instance, in December 2022, Chinese clinics announced the launch of a drive-through IV Infusion system to help deal with the overwhelming number of COVID patients.

Key Companies & Market Share Insights

The market for IV hydration therapy is fragmented, with most of the market share held by several small companies. Market players are focusing on adopting several strategies, including product launches, strategic collaborations, and acquisitions, to strengthen their presence, further contributing to the market growth. For instance, in April 2023, Jason Thompson, a former NBA player, in collaboration with LaNette Keeton, an IV infusions and therapy specialist, announced the launch of Hydrate IV Therapy & Wellness, a new brand for wellness and hydration therapy service in New Jersey. Some of the key players in the global IV hydration therapy market include:

• Core IV Therapy, LLC

• Cryojuvenate UK Ltd.

• B. Braun Medical Inc.

• Otsuka Pharmaceutical Co., Ltd.

• NexGen Health

• JW Life Science Corporation

• Amanta Healthcare

• Baxter International Inc.

• Drip Hydration

Intravenous (IV) Hydration Therapy Market Report Scope

Global Intravenous (IV) Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global intravenous (iv) hydration therapy market report based on service, component, end-use, and region:

• Service Outlook (Revenue, USD Billion, 2018 - 2030)

  • Immune Boosters

  • Energy Boosters

  • Skin Care

  • Migraine

  • Others

• Component Outlook (Revenue, USD Billion, 2018 - 2030)

  • Medicated

  • Non-medicated

• End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals & Clinics

  • Wellness Centers & Spas

  • Home Healthcare

  • Others

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait